Neuregulin-1 (NRG1) signaling participates in numerous neurodevelopmental processes. Through linkage analysis, nrg1 has been associated with schizophrenia, although its pathophysiological role is not understood. The prevailing models of schizophrenia invoke hypofunction of the glutamatergic synapse and defects in early development of hippocampalcortical circuitry. Here, we show that the erbB4 receptor, as a postsynaptic target of NRG1, plays a key role in activity-dependent maturation and plasticity of excitatory synaptic structure and function. Synaptic activity leads to the activation and recruitment of erbB4 into the synapse. Overexpressed erbB4 selectively enhances AMPA synaptic currents and increases dendritic spine size. Preventing NRG1/erbB4 signaling destabilizes synaptic AMPA receptors and leads to loss of synaptic NMDA currents and spines. Our results indicate that normal activity-driven glutamatergic synapse development is impaired by genetic deficits in NRG1/ erbB4 signaling leading to glutamatergic hypofunction. These findings link proposed effectors in schizophrenia: NRG1/erbB4 signaling perturbation, neurodevelopmental deficit, and glutamatergic hypofunction.
INTRODUCTION
The function of NRG1 in the brain has gained much attention since the initial discovery (Stefansson et al., 2002) and subsequent confirmation Harrison and Weinberger, 2005; Scolnick et al., 2006 ) that nrg1 gene is linked to schizophrenia. Further studies showed that erbB4, a receptor of NRG1, is also associated with schizophrenia (Law et al., 2007; Norton et al., 2006a; Silberberg et al., 2006) . A change in the expression level of NRG1 isoforms (Hashimoto et al., 2004; Law et al., 2006; Petryshen et al., 2005) or erbBs (Hakak et al., 2001; Silberberg et al., 2006; Sugai et al., 2004 ) has been reported in schizophrenia patients. These studies strongly support the hypothesis that a perturbation in NRG1 signaling in the brain can contribute to the etiology of schizophrenia.
NRG1 has multiple biological functions (Falls, 2003) . In the peripheral nervous system (PNS), it regulates target cell differentiation (Hippenmeyer et al., 2002) , neurotransmitter receptor expression (Buonanno and Fischbach, 2001; Chu et al., 1995; Falls et al., 1993; Fischbach and Rosen, 1997; Jo et al., 1995; Schaeffer et al., 2001; Usdin and Fischbach, 1986; Wolpowitz et al., 2000) , NMJ or interneuronal PNS synapse development (Lin et al., 2000; Morris et al., 1999; Woldeyesus et al., 1999; Wolpowitz et al., 2000; Yang et al., 1998) , and Schwann cell survival (Escher et al., 2005; Kummer et al., 2006) .
In the brain, NRG1 signaling regulates radial glia formation and neuronal migration (Anton et al., 1997; Rio et al., 1997) , oligodendrocyte development and axon myelination (Calaora et al., 2001; Canoll et al., 1996; Fernandez et al., 2000; Schmucker et al., 2003; Vartanian et al., 1994 Vartanian et al., , 1999 , axon path finding (Lopez-Bendito et al., 2006) , dendritic development (Gerecke et al., 2004; Rieff and Corfas, 2006) , and the expression of neurotransmitter receptors (Liu et al., 2001; Okada and Corfas, 2004; Ozaki et al., 1997; Rieff et al., 1999; Stefansson et al., 2002; Xie et al., 2004) .
NRG1 function is largely mediated by a class of receptor tyrosine kinases including erbB2, erbB3, and erbB4 (Falls, 2003; Yarden and Sliwkowski, 2001) . ErbB4 is likely to be the major mediator of NRG1 functions in the brain, especially for those related to schizophrenia, since first, erbB4, but not erbB2 or erbB3, mutant animals share many neural and behavioral defects with NRG1 mutants (Falls, 2003; Stefansson et al., 2002) ; second, erbB4 gene, but not erbB2 or 3, has been shown to associate with schizophrenia (Law et al., 2007; Norton et al., 2006a; Silberberg et al., 2006) ; third, altered NRG1/erbB4 signaling has been reported in the brain of schizophrenia patients (Hahn et al., 2006) .
In many brain areas, NRG1 is expressed at synaptic regions (Chaudhury et al., 2003; Law et al., 2004; Ozaki et al., 2000) , and its processing can be regulated by neuronal activity (Bao et al., 2003; Eilam et al., 1998; Ozaki et al., 2004) . Recent biochemical studies showed that erbB4 is highly enriched in the postsynaptic density (PSD) of excitatory synapses and interacts with PSD-95 (Garcia et al., 2000; Huang et al., 2000) , a major scaffolding protein in the excitatory synapse that can control synaptic function (Ehrlich and Malinow, 2004; El-Husseini et al., 2000) , suggesting an important role of erbB4 in these synapses. Moreover, in the hippocampus, NRG1 mRNA is highly expressed in the CA3 area, a region presynaptic to the CA1 area which displays erbB4 expression (Law et al., 2004; Okada and Corfas, 2004) . These findings suggest that NRG1/erbB4 signaling might be important for the function or development of glutamatergic synapse and circuitry in the brain.
Here, by manipulating NRG1/erbB4 signaling at the hippocampal CA3-CA1 pathway, we demonstrate that postsynaptic erbB4 controls activity-dependent maturation and plasticity of excitatory synaptic structure and function. In particular, NRG/erbB4 signaling is positively regulated by synaptic activity. In turn, NRG/erbB4 signaling is also required for activity-dependent AMPA receptor synaptic incorporation and stabilization as well as maintenance of spine structure. As a result, interruption of signaling from presynaptic NRG1 to postsynaptic erbB4 leads to impaired synaptic development and depressed glutamatergic function. Our study indicates that NRG1/erbB4 signaling plays an important role in glutamatergic synapses and suggests a mechanism by which genetic or activitydependent perturbation of this pathway can contribute to the etiology of schizophrenia.
RESULTS

Neuronal Activity Regulates ErbB4 Activation and Localization
Previous biochemical studies have shown that erbB4 is enriched in the PSD fraction of excitatory synapse in the brain (Garcia et al., 2000; Huang et al., 2000) . However, it is not clear how erbB4 synaptic localization is achieved and how its localization and function are regulated. Since NRG1 processing or release is regulated by neuronal activity (Bao et al., 2003; Eilam et al., 1998; Han and Fischbach, 1999; Ozaki et al., 2004) , we hypothesized that neuronal activity also regulates erbB4 activation and its recruitment and stabilization in the synapse. We predicted that synaptic erbB4 should have a higher phosphorylation level than extrasynaptic erbB4, and changing neuronal activity should change erbB4 phosphorylation and distribution. As expected, erbB4 isolated from the PSD fraction displayed a greater degree of phosphorylation than erbB4 in the brain homogenate (homogenate, 1 ± 0.05; PSD, 4.1 ± 0.55; n = 4 experiments; p < 0.01; Figure 1A ), indicating synaptic erbB4 is preferentially activated. Moreover, increasing neuronal activity by treating hippocampal slices with picrotoxin for 1 hr markedly increased erbB4 phosphorylation in the PSD (control, 1 ± 0.1; picrotoxin, 5 ± 0.3; n = 4 experiments; p < 0.01; Figure 1B ), whereas inhibiting neuronal activity by elevated concentration of MgCl 2 (Zhu et al., 2000) or TTX for 1 hr significantly decreased erbB4 phosphorylation in the PSD (control, 1 ± 0.12; MgCl 2 , 0.23 ± 0.08; TTX, 0.16 ± 0.06; n = 3 experiments; p < 0.01 for both MgCl 2 and TTX compared with control; Figures 1C and 1D) . Interestingly, inhibition of neuronal activity also reduced the total amount of erbB4 in the PSD fraction ( Figures 1C and 1E ).
To directly visualize the subcellular distribution of erbB4, we tagged recombinant erbB4 in the extracellular region with a pH-sensitive form of GFP, super-ecliptic pHluorin (SEP), which we have previously shown to be a marker for receptors on the cell surface (Kopec et al., 2006) . After transfection of CA1 pyramidal cells in organotypic hippocampal slices with SEP-erbB4 together with a red fluorescent protein, tomato DsRed, as a cellular marker, the subcellular distribution of erbB4 was examined by dual-channel two-photon laser-scanning microscopy (TPLSM) (Kopec et al., 2006) . We found that SEPerbB4 is highly enriched on the surface of spines of CA1 pyramidal cells (Figures 1F, 1G, and 1H) .
Consistent with the biochemical results, our imaging data also showed that erbB4 subcellular localization is regulated by neuronal activity. When transfected slices are maintained in normal media, SEP-erbB4 is highly enriched on the surface of spines. However, maintaining slices with elevated concentration of Mg 2+ markedly reduced this enrichment (normal media, 47 ± 6.3, n = 212 spines from three cells; Mg 2+ -treated, 5.9 ± 0.1, n = 266 spines from four cells; p < 0.01; Figures 1G, 1H , and 1I). To test if erbB4 activation is required for its spine enrichment, we expressed an erbB4 mutant that lacks the kinase activity due to a point mutation in the kinase domain, which has been shown to function as a dominant-negative erbB4 (Yang et al., 2005) . The kinase-dead erbB4 (SEPerbB4-KD) is much less enriched on the surface of spine (11.1 ± 0.3, n = 417 spines from four cells; p < 0.01 compared with SEP-erbB4). Treatment with Mg 2+ further reduced the enrichment of SEP-erbB4-KD on the spine surface (6.4 ± 0.2, n = 163 spines from four cells; p < 0.01 compared with nontreated SEP-erbB4-KD; Figures 1G, 1H, and 1I). These data indicate that neuronal activity regulates erbB4 activation and erbB4 activation is required for its synaptic recruitment or stabilization and suggest that erbB4 plays an important role in glutamatergic synapses.
Activity-Dependent ErbB4 Regulation of Synaptic Transmission
To test if erbB4 is important for synaptic function at hippocampal CA3-CA1 synapse, we first examined the effects of erbB4 overexpression on synaptic transmission by simultaneous recordings of evoked EPSCs from a CA1 pyramidal neuron overexpressing erbB4 and an adjacent control neuron. Overexpression of either nontagged erbB4 (together with GFP as a cellular marker) or SEP-erbB4 results in a potentiation of AMPA receptor (AMPAR)-mediated transmission (control, 1 ± 0.1; erbB4, 1.8 ± 0.2; n = 31 pairs; p < 0.01), but not NMDA receptor (NMDAR)-(control, 1 ± 0.2; erbB4, 0.83 ± 0.1; n = 27 pairs; p > 0.05) mediated transmission (Figure 2A ). Overexpression of erbB4 isoform CYT-1, or isoform CYT-2, which lacks a PI3-kinase binding domain, had similar effects (data not shown), suggesting that the PI3-kinase binding domain is not required for potentiating AMPAR-mediated synaptic transmission.
To examine the function of endogenous erbB4, we employed RNA interference (RNAi) to knock down erbB4 protein level. Neurons were infected with a Lenti virus expressing, via a dual-promoter system, GFP (as a marker for infected cells) and short hairpin RNAs specifically targeting different regions of erbB4 transcript. Three different short hairpin RNAs reduced erbB4 protein expression to different degrees, with hairpin number two (hp2) being most effective (see Figure S1A in the Supplemental Data available with this article online). After infecting CA1 cells, hp2 significantly depressed both AMPAR-(control, 1 ± 0.2; hp2, 0.65 ± 0.1; n = 10 pairs; p < 0.05) and NMDAR-(control, 1 ± 0.1; hp2, 0.67 ± 0.1; n = 8 pairs; p < 0.05) mediated transmission ( Figure 2B ). Hp3 also depressed synaptic transmission, whereas hp1, which was less effective in knocking down erbB4 expression, failed to suppress transmission ( Figure S1B ). To further test the specificity of erbB4 RNAi, hp2 was expressed together with an erbB4 construct that has silent mutations that avoid targeting by hp2 (erbB4-rescue). Like expressing erbB4 alone, expressing of hp2 together with erbB4-rescue resulted in a potentiation of AMPAR-mediated transmission but no effect on NMDAR-mediated transmission ( Figure S1C ), indicating that erbB4 RNAi is specific.
To determine whether the kinase activity of erbB4 or other functional domains are responsible for the effects of erbB4, we tested the effects of erbB4-KD. ErbB4-KD depressed both AMPAR-(control, 1 ± 0.1; erbB4-KD, 0.47 ± 0.1; n = 16 pairs; p < 0.01) and NMDAR-(control, 1 ± 0.2; erbB4-KD, 0.55 ± 0.1; n = 14 pairs; p < 0.05) mediated transmission ( Figure 2C ), similar to the effects of erbB4 RNAi, suggesting erbB4-KD functions as a dominant-negative. These data indicate that erbB4 controls excitatory synaptic transmission at the CA3-CA1 synapse.
Since erbB4 activation and synaptic localization are activity dependent, it is likely that the function of NRG1/ erbB4 in the glutamatergic synapse also depends on neuronal activity. To test this, we incubated organotypic hippocampal slices in medium containing elevated concentration of Mg 2+ and then tested the effects of erbB4 and erbB4-KD on synaptic transmission in CA3-CA1 synapse. Mg 2+ treatment prevented the potentiation effect of erbB4 on AMPAR-mediated transmission (AMPAR, control 1 ± 0.2; erbB4 0.83 ± 0.1; n = 10 pairs; p > 0.05; NMDAR, control 1 ± 0.2; erbB4 0.68 ± 0.1; n = 9 pairs; p > 0.05; Figure 2D) and occluded the depression effects of erbB4-KD on both AMPAR-and NMDAR-mediated transmission (AMPAR, control 1 ± 0.1; erbB4 0.83 ± 0.1; n = 9 pairs; p > 0.05; NMDAR, control 1 ± 0.1; erbB4 0.95 ± 0.1; n = 9 pairs; p > 0.05; Figure 2E ). APV also blocked the potentiating effect of erbB4 (AMPAR, control 1 ± 0.1; erbB4 0.63 ± 0.1; n = 8 pairs; p > 0.05; NMDAR, control 1 ± 0.2; erbB4 0.61 ± 0.2, n = 7 pairs; p > 0.05; Figure 2D ), indicating that NMDAR activation is involved. Treatment with either Mg 2+ or APV had a tendency to depress transmission. Since blocking activity inhibited phosphorylation of synaptic erbB4 ( Figure 1 ) but not extrasynaptic erbB4 (data not shown), overexpression of erbB4 in the presence of activity blockers would shift erbB4 activation pattern away from the synapse. This may trap glutamate receptors away from the synapse (see below). An erbB4 kinase inhibitor, AG1478 (Fukazawa et al., 2003) , also prevented the effects of erbB4 and occluded the effects of erbB4-KD ( Figures 2D and 2E ). These data further indicate that normal spontaneous neuronal activity is required to activate erbB4, and activation of erbB4 kinase is necessary for its synaptic function.
ErbB4 Regulates Synaptic Maturation
ErbB4 might affect synaptic transmission by controlling synaptic maturation that occurs during the period that constructs are expressed. To test this hypothesis, we examined the effects of erbB4 RNAi on miniature EPSC (mEPSC) of CA1 pyramidal cells. Normally, there is a significant increase in mEPSC frequency (4 DIV, 3.3 ± 0.7 per min, n = 10 cells; 7 DIV, 17.5 ± 4.5 per min, n = 10 cells; p < 0.05) and a small increase in mEPSC amplitude (4 DIV, 21.7 ± 0.8 pA, n = 300 events from 10 cells; 7 DIV, 25.8 ± 0.5 pA, n = 1330 events from 10 cells; p < 0.05) during early development of CA3-CA1 synapse (Figures 3A-3D ; Barria and Malinow, 2005) . The maturation process of excitatory synapse involves spontaneous activity-dependent plasticity (SAP) (Barria and Malinow, 2005; Kolleker et al., 2003; Zhu et al., 2002) , which shares many properties with a more acute form of plasticity, long-term potentiation (LTP), including its dependence on CaMKII and NMDAR activation (Barria and Malinow, 2005) . ErbB4 RNAi largely arrested the increase in mEPSC frequency during development (4 DIV, 2.8 ± 0.6 per min, n = 8 cells; 7 DIV, 6.4 ± 2.3 per min, n = 10 cells; p > 0.05; Figures 3B and 3C ) without significantly influencing mEPSC amplitude (4 DIV, 22.4 ± 1.1 pA, n = 212 events from 8 cells; 7 DIV, 24.9 ± 0.8 pA, n = 461 events from 10 cells; p > 0.05 compared with control for both developmental stages; Figure 3D ). These data indicate that erbB4 mediated signaling is critical for normal synaptic maturation.
ErbB4 Is Critical in Maintaining Spine Morphology
Since erbB4 controls synaptic maturation, it is reasonable to speculate that erbB4 signaling also controls the size or number of dendritic spines, where excitatory synapses are placed (Harris and Kater, 1994) . Indeed, erbB4 RNAi dramatically reduced spine density (control, 0.45 ± 0.03 per mm, n = 26 dendritic sections from six cells; erbB4 RNAi, 0.22 ± 0.03 per mm, n = 21 dendritic sections from 6 cells; p < 0.01; Figures 4A and 4C) and also significantly reduced spine size, although to a lesser extent (control, 1 ± 0.03, n = 540 spines from six cells; erbB4 RNAi, 0.8 ± 0.04, n = 221 spines from six cells; p < 0.01; Figure 4B ). On the other hand, overexpression of erbB4 increased spine size (control, 1 ± 0.08, n = 303 spines from four cells; erbB4, 1.5 ± 0.08, n = 291 spines from four cells; p < 0.01; Figures 4D and 4E) but did not affect spine density (control, 0.6 ± 0.05 per mm, n = 9 dendritic sections from four cells; erbB4, 0.58 ± 0.08 per mm, n = 10 dendritic sections from four cells; p > 0.05; Figure 4F ). This suggests that erbB4 activity is critical for the maintenance of existing spines but is not sufficient for the formation of new spines. Interestingly, erbB4-KD only reduced spine size (erbB4-KD, 0.8 ± 0.04, n = 337 spines from four cells; p < 0.05 compared with control; Figures 4D and 4E ) but did not change spine density (erbB4-KD, 0.56 ± 0.03 per mm, n = 9 dendritic sections from four cells; p > 0.05 compared with control; Figure 4F ), an effect that is different from erbB4 RNAi ( Figure 4C ). Since erbB4-KD still has other functional domains intact, such as the PDZ ligand domain (see below), it is likely that domains in erbB4 other than the kinase domain are also involved in maintaining spine structure.
The PDZ Interaction Is Important for ErbB4 Function
Previous studies have shown that the C-terminal end of erbB4 interacts with the PDZ domains of MAGUK proteins including PSD-95, and this interaction regulates the activation of erbB4 kinase (Huang et al., 2000; Xie et al., 2007) . To test whether the erbB4 interaction with a MAGUK protein is important for its synaptic function, we expressed an erbB4 mutant, erbB4-DV, which has a single amino acid deletion at the very end of C terminus that abolishes its PDZ interaction (Huang et al., 2000) . ErbB4-DV lost the ability to enlarge spine size (control, 1 ± 0.06, n = 200 spines from three cells; erbB4-DV, 1 ± 0.05; n = 229 spines from four cells; p > 0.05; Figures 5A-5C ) and potentiate synaptic transmission (control AMPA, 1 ± 0.1; erbB4-DV AMPA, 1 ± 0.1, n = 13 pairs, p > 0.05; control NMDA, 1 ± 0.1; erbB4-DV NMDA, 0.86 ± 0.16, n = 12 pairs, p > 0.05; Figure 5D ). Moreover, erbB4-DV is less enriched in the spine compared with wild-type erbB4 (erbB4, 47 ± 6.3, n = 212 spines from three cells; erbB4-DV, 31 ± 4, n = 229 spines from four cells; p < 0.01; Figure 5E ) likely due to its inefficiency in activation (Huang et al., 2000) , since activation of erbB4 is required for its spine enrichment (see Figure 1) . However, it is also possible that interaction with a MAGUK protein directly controls erbB4 trafficking. We conclude that, besides the kinase domain, the PDZ ligand domain of erbB4 is also important for its proper synaptic localization and function.
ErbB4 Mediates the Function of NRG1
Although there is evidence showing that NRG1 is expressed in axons in the PNS (Fernandez et al., 2000; Taveggia et al., 2005) , it is not clear if NRG1 is expressed in the presynaptic terminals of CNS glutamatergic synapse, mainly due to the lack of a high quality antibody to visualize the subcellular localization of NRG1. Moreover, since erbB4 has ligands other than NRG1 and erbB4 can form functional heteromers with other receptors such as erbB1 (Carpenter, 2003) , a perturbation of erbB4 function may disrupt signaling pathways other than that mediated by NRG1. To directly address these questions, we employed RNAi to knock down the expression of endogenous NRG1 in the presynaptic, CA3 pyramidal neurons. Three hairpin-like RNAs that target sequences that are shared by all major NRG1 isoforms, types I, II, and III, were expressed using Lenti viruses that coexpress GFP or tDimer DsRed to serve as infection markers. The effect of the hairpins on NRG1 expression was confirmed in both hippocampal neurons and HEK293 cells transfected with different NRG1 isoforms ( Figures S2A-S2D) . A hairpin that effectively reduced the expression of both NRG1 type I and III was used for subsequent experiments. We reasoned that if the effects of erbB4 manipulation, as described above, are due to a disruption of presynaptic NRG1-mediated signaling, presynaptic knock down of NRG1 would occlude these effects. That is, a postsynaptic cell not expressing erbB4 RNAi would be depressed by presynaptic NRG1 RNAi to the same level as a postsynaptic cell expressing erbB4 RNAi. To test this, we infected CA3 area with a high-titer Lenti virus expressing NRG1 RNAi together with tDimer. CA1 area was infected with low-titer Lenti virus expressing erbB4 RNAi together with GFP. A stimulating electrode was positioned in the heavily infected (red) cell body area in CA3 ( Figure 6A ) to activate CA3 axons expressing NRG1 RNAi. Simultaneous recordings of evoked EPSCs were made from paired noninfected and erbB4 NRAi-infected (green) pyramidal cells in the CA1 region ( Figure 6A ). As expected for occlusion, the depressing effects of erbB4 RNAi on both AMPARand NMDAR-mediated transmission were abolished by NRG1 knockdown (AMPAR, control 1 ± 0.2, erbB4 RNAi 1.1 ± 0.1, n = 18 pairs, p > 0.05; NMDAR, control 1 ± 0.2, erbB4 RNAi 0.85 ± 0.2, n = 17 pairs, p > 0.05; Figures 6B  and 6D ). When presynaptic NRG1 RNAi was expressed together with a NRG1 construct with silent mutations that avoid RNAi targeting, the effects of postsynaptic expression of erbB4 RNAi on synaptic transmission were restored, suggesting that NRG1 RNAi is specific ( Figure S2E ). Furthermore, similar results were also obtained for erbB4-KD (AMPAR, control 1 ± 0.1, erbB4-KD 0.87 ± 0.1, n = 14 pairs, p > 0.05; NMDAR, control 1 ± 0.2, erbB4-KD 0.99 ± 0.2, n = 12 pairs, p > 0.05; Figures 6C  and 6E ). These results indicate that postsynaptic erbB4 mediates the function of presynaptic NRG1 to control CA3-CA1 synapses.
NRG1/erbB4 Signaling Is Critical for Structural and Functional Synaptic Plasticity
Since NRG1/erbB4 regulates spontaneous activity-dependent plasticity (SAP), which shares mechanisms with LTP, we speculated that NRG1/erbB4 might also be important for LTP. To test this, either SEP-erbB4 or SEPerbB4-KD was expressed in CA1 pyramidal cells, and the slices were incubated in elevated Mg 2+ during the period of both erbB4 and erbB4-KD expression, which normalizes NMDA current between infected and noninfected cells ( Figures 2D and 2E ). This will preclude the effect of NMDA receptor depression on synaptic plasticity. A chemical form of LTP (cLTP) (Kopec et al., 2006) combined with TPLSM was employed to track changes in individual spines induced by synaptic plasticity. Similar to what we have shown previously, cLTP, which induces transient synchronized neuronal bursting in organotypic slices (Kopec et al., 2006) , induced a rapid and persistent increase in spine size (spine size at 5, 40, and 70 min was 1.7 ± 0.1, 1.6 ± 0.1, and 1.7 ± 0.1, respectively, over base line; n = 135 spines from four cells; p < 0.01 for each time point; Figure 7A ). In addition, cLTP also induced a rapid and persistent increase in the amount of erbB4 receptors on the surface of spines (spine SEP-erbB4 at 5, 40, and 70 min was 1.36 ± 0.1, 1.24 ± 0.1, and 1.27 ± 0.1, respectively, over base line; n = 135 spines from four cells; p < 0.01 for 5 min and p < 0.05 for 40 and 70 min time points; Figure 7A ), further supporting the finding that neuronal activity recruits erbB4 into the synapse. The increase of erbB4 on the spine surface is unlikely to be a passive recruitment due to the increase in spine size, as other surface proteins, such as NMDARs, do not increase in spines during cLTP (Kopec et al., 2006) . On the other hand, SEPerbB4-KD largely prevented the spine size increase induced by cLTP (spine size at 5, 40, and 70 min was 1.2 ± 0.1, 1 ± 0.1, and 1.1 ± 0.1, respectively, over base line; n = 121 spines from four cells; p < 0.01 compared with SEPerbB4 for each time point; Figure 7B ), and cLTP did not increase the content of SEP-erbB4-KD on spine surface (spine SEP-erbB4-KD at 5, 40, and 70 min was 1 ± 0.04, 0.87 ± 0.04, and 0.98 ± 0.1, respectively, over base line; n = 135 spines from four cells; p > 0.05; Figure 7B ). This suggests that the normal NRG1/erbB4 signaling is required for cLTP induction and erbB4 trafficking. Activity-dependent activation of erbB4 might result from the activity-dependent processing or release of NRG1 from the presynaptic termini, since it has been shown that NRG1 type I expression, processing, or release is regulated by neuronal activity, including LTP like stimulation (Eilam et al., 1998; Han and Fischbach, 1999; Ozaki et al., 2004) . Less is known about the activity-dependent regulation of NRG1 type III, although its processing has also been shown to be activity dependent (Bao et al., 2003) . To directly visualize NRG1 type III, we tagged NRG1 type III with SEP in the extracellular region (Wang et al., 2001) . After infection of pyramidal neurons with a double-promoter Sindbis virus expressing SEP-NRG1 type III together with tDimer as a morphological marker, the subcellular distribution of SEP-NRG1 type III was examined with TPLSM. SEP-NRG1 type III was readily detectable on the surface of axons, especially on bouton-like structures ( Figure 7C ). To test if the distribution of NRG1 is regulated by neuronal activity, time-lapse TPLSM was used to monitor SEP-NRG1 type III before, during, and after cLTP. We quantified the amount of NRG1 on the boutons or axons as the ratio of the mean green signal (SEP-NRG1) to the mean red signal (tDimer), which serves as a relative density of NRG1 on those structures (Kopec et al., 2006) . The cLTP significantly reduced the amount of NRG1 type III on the surface of axon boutons (bouton NRG1 at 40 and 70 min were 0.85 ± 0.04 and 0.81 ± 0.03 over base line; n = 32 boutons from four cells, p < 0.05; Figure 7C ) and also reduced the amount on other axonal regions (axonal NRG1 at 40 and 70 min were 0.93 ± 0.05 and 0.87 ± 0.05 over base line; n = 32 regions from four cells, p < 0.05; Figure 7C ). The decrease in NRG1 density is not due to a change in bouton size, since boutons did not enlarge after cLTP ( Figure 7C ). The red signal on the axons was stable during the period of experiments, suggesting the cell condition was good and photo bleaching was minimal. The reduction in the surface NRG1 type III may result from the processing and subsequent endocytosis of the surface NRG1, suggesting that the EGF domain on a subpopulation of NRG1 type III was briefly exposed and presented to its receptors during cLTP.
To test further whether NRG1/erbB4 is also required for the conventional, electrically induced LTP, we compared LTP in CA1 control pyramidal cells or cells expressing erbB4-KD. ErbB4-KD significantly reduced LTP (control, n = 7; erbB4-KD, n = 7; p < 0.05 measured between 35 to 45 min; Figure 7D ). Similarly, cells expressing erbB4 RNAi also had reduced LTP compared with cells expressing only GFP (GFP, n = 16 reduced to 13; erbB4 RNAi, n = 16; p < 0.05 measured between 35 to 45 min; Figure 7E ). We conclude that the normal NRG1/erbB4 signaling is necessary for both structural and functional LTP.
NRG1/erbB4
Regulates Synaptic Function and Structure by Stabilizing AMPA Receptors A previous study from our laboratory showed that the synaptic depression and spine loss resulting from increased levels of b amyloid can be blocked by stabilizing AMPA receptors in the synapse (Hsieh et al., 2006) . To test whether stabilizing AMPA receptors could prevent the defect in synaptic transmission and spine morphology caused by NRG1/erbB4 loss of function, we examined the effects of a peptide derived from the AMPA receptor gluR2 C terminus. This peptide, gluR2-3Y, has been shown to stabilize AMPA receptors in the synapse (Ahmadian et al., 2004) . Strikingly, incubation of slices with gluR2-3Y abolished the effects of erbB4 RNAi on both synaptic transmission (AMPA control, 1 ± 0.1; AMPA erbB4 RNAi, 1 ± 0.1, n = 16 pairs, p > 0.05; NMDA control, 1 ± 0.2; NMDA erbB4 RNAi, 0.97 ± 0.2, n = 14 pairs, p > 0.05; Figure 8A ) and spine morphology (spine size, control 1 ± 0.05, n = 302 spines from four cells; erbB4 RNAi, 0.9 ± 0.05, n = 317 spines from four cells, p > 0.05; spine density, control 0.54 ± 0.04, n = 12 dendritic sections from four cells; erbB4 RNAi 0.52 ± 0.04, n = 13 dendritic sections from four cells; p > 0.05; Figures 8C-8E) . Incubation of slices with a mutant version of the peptide, gluR2-3A, which has no effects on AMPA receptor synaptic stabilization (Ahmadian et al., 2004) , had no effects on erbB4 RNAi-induced synaptic depression (AMPA control, 1 ± 0.1; AMPA erbB4 RNAi, 0.68 ± 0.1, n = 16 pairs, p < 0.01; NMDA control, 1 ± 0.2; NMDA erbB4 RNAi, 0.7 ± 0.1, n = 14 pairs, p < 0.05; Figure 8B ). These results indicate that NRG1/erbB4 signaling controls synaptic function and structure by regulating AMPA receptor stabilization in the synapse.
DISCUSSION
A prominent hypothesis regarding the underlying pathophysiology of schizophrenia has proposed that hypofunction of the glutamatergic system plays a causal role (Coyle and Tsai, 2004; Harrison, 2004; Harrison et al., 2003; Harrison and Weinberger, 2005) . In humans, reducing glutamatergic transmission can mimic (Pietraszek, 2003) , while enhancing gluamatergic transmission can alleviate (Javitt, 2004) , schizophrenic symptoms. Patients with the disease show decreased excitatory synaptic function in hippocampal and cortical regions (Abbott and Bustillo, 2006; Bressan and Pilowsky, 2000; Pilowsky et al., 2006) .
Another feature thought to be important in the disease is its neurodevelopmental nature. For example, animals with lesions that disrupt the excitatory connections between hippocampus and the frontal cortex early in development show schizophrenic-like symptoms later in life (Bertolino et al., 1997; Daenen et al., 2003; Lipska, 2004; Van den Buuse et al., 2003) . Human studies also suggest that pre-or perinatal brain lesions may lead to schizophrenia by disrupting early brain maturation processes including those in the hippocampus (Pantelis et al., 2005; Rehn et al., 2005) . It is thus believed that perturbation of circuitry formation early in life can predispose to the disease.
Schizophrenia is also a genetic disease. With the advent of molecular genetics, a number of genes have been linked to schizophrenia (Harrison and Weinberger, 2005) . The gene with most supportive evidence is nrg1 (Harrison and Weinberger, 2005; Norton et al., 2006b) .
Despite these advances in the field, there has not been a mechanism that can link genetic perturbation of NRG1 signaling to glutamatergic hypofunction or developmental abnormalities.
In this study, we examined the function of NRG1/erbB4 signaling in the excitatory CA3-CA1 synapse in the hippocampus. Our data support a model in which synaptic activity leads to the activation of NRG1/erbB4 signaling pathway, which recruits or stabilizes erbB4 in the synapse in a manner that depends on erbB4 PDZ interaction. Activity-dependent NRG1/erbB4 activation stabilizes synaptic AMPA receptors and thus permits synaptic plasticity and synaptic maturation ( Figure 8F ). Interruption of NRG1/ erbB4 signaling causes destabilization of synaptic AMPARs and spine structure, leading to impairment in plasticity and eventually loss of spines and NMDARs. These results therefore provide a direct link between NRG1 and glutamatergic function. Decreased NRG1/ erbB4 signaling (which could be longer term but more modest than the knockdown or dominant-negative perturbations in this study) would likely have manifestations on excitatory circuit development by inhibiting normal functional and structural synaptic maturation. Thus, our study provides a link between nrg1 and the ''glutamatergic hypofunction'' hypothesis as well as with the view that development of early circuitry is an important underlying factor in schizophrenia.
We found an interesting relationship between NRG1/ erbB4 signaling and synaptic activity. Synaptic activity is required for NRG1/erbB4 signaling, and NRG1/erbB4 signaling enhances synaptic function. Such positive-feedback relationships could lead to a switch-like behavior, where too little activity would lead to a weakening of the synapse and achieving a threshold level of activity would lead to its saturation. Since synapses appear to display intermediate strengths, there are likely to be other signaling systems that strongly modulate this switch-like function. Aberrations of these other modulatory signaling systems would likely abrogate NRG1/erbB4 signaling and could contribute to schizophrenia. Our finding that NRG1/erbB4 signaling depends on synaptic activity indicates that the well-known impact of experience on synaptic structure and function is likely to act, at least in part, through this signaling pathway.
Several recent studies have examined the acute effects of NRG1 on synaptic function in the CNS. NRG1 application has been shown to inhibit synaptic plasticity (Huang et al., 2000; Kwon et al., 2005; Ma et al., 2003) and to reduce NMDA receptor activity (Gu et al., 2005) or synaptic transmission (Roysommuti et al., 2003) . However, the interpretation of these data is complicated since these studies employed tonic application of a functional domain (such as the EGF domain) of certain isoforms of recombinant NRG1 (Gu et al., 2005; Huang et al., 2000; Kwon et al., 2005; Ma et al., 2003; Roysommuti et al., 2003) , and little is known about the physiological concentration, activity duration, location of activity (Woo et al., 2007) , specific NRG1 isoforms involved, as well as different erbB receptors being activated by such application. The function of endogenous NRG1 in the synapse may thus be different. Indeed, NRG1-deficient mice have reduced NMDA receptor activity compared with wild-type (Stefansson et al., 2002) , rather than increased NMDA receptor activity as would be predicted from the acute application studies.
In conclusion, our study indicates a mechanism by which core features of schizophrenia, including genetic deficits, developmental abnormalities, and glutamatergic hypofunction can be linked together. The direct and chronic perturbation of NRG1/erbB4 signaling, such as mutations in NRG1 or erbB4 genes that occur in some schizophrenia patients (Walss-Bass et al., 2006) , would lead to the abnormal development and hypofunction of glutamatergic synapse and circuitry. Supporting this view, a decrease in spine density and other markers for excitatory synapses has been reported in the brain of schizophrenia patients (Eastwood, 2004; Harrison et al., 2003; Kristiansen et al., 2006; Lewis et al., 2003) . Mutations in nrg1 or erbB4 genes likely account for only a fraction of schizophrenia cases (Harrison and Weinberger, 2005) . For other patients, there may be defects in other signaling or structural components producing hypofunction in the glutamatergic pathway, and a compensatory increase in NRG1/erbB4 activity or expression level might be expected. Indeed, an increase in the expression level of NRG1 isoforms (Hashimoto et al., 2004; Law et al., 2006; Petryshen et al., 2005) or erbB4 (Silberberg et al., 2006) , as well as an increase in the activity of the NRG1/ erbB4 signaling pathway (Hahn et al., 2006) , have been found in some schizophrenia patients.
EXPERIMENTAL PROCEDURES
Biochemistry on PSD Fraction, Immunoprecipitation and Western Blotting These procedures were conducted using standard protocols, for details, see Supplemental Data.
Plasmid Construction
The superecliptic pHluorin (SEP) coding sequence (Ng et al., 2002) was inserted after the predicted signal peptide cleavage site of human erbB4 CYT-2 isoform. The resultant product was inserted into the mammalian expression vector pCDNA3 (Invitrogen). The kinase-inactive mutant erbB4-KD contains a point mutation (K751M) in the kinase domain. The red fluorescent proteins (tDimer or tomato DsRed), fastmaturing obligate dimer versions of DsRed (provided by R. Tsien, University of California San Diego, La Jolla, CA), were inserted into either pCI (Promega) or pCDNA3. To generate SEP-NRG1, SEP was inserted into an extracellular region of either NRG1 type I or type III. This region has been previously used to insert a HA or GFP tag (Ozaki et al., 2004; Wang et al., 2001) . To facilitate imaging of SEP-NRG1, the SEP-NRG1 type III was cloned into a double-promoter Sindbis viral vector that express both SEP-NRG1 and tDimer. The double-promoter Sindbis vector was a gift from Dr. H. Nawa.
Short Hairpin RNA-Based RNA Interference for ErbB4 and NRG1 To suppress the expression of endogenous erbB4 or NRG1, short hairpin RNAs specifically against rat erbB4 or NRG1 were stably expressed using a strategy developed in the Hannon lab (Paddison et al., 2002) . To suppress erbB4 or NRG1 expression in neurons, Lenti virus was used to express both short hairpin RNAs, which is driven by the U6 promoter (Paddison et al., 2002) , and GFP or tDimer, which is driven by the Ubiquitin or Synapsin promoter, to visualize the infected neurons. The Lenti viral construct, which is similar to what has been described previously (Dittgen et al., 2004) , was a gift from Dr. G. Hannon. The target sequences of three short hairpin RNAs for erbB4 are as follows:
The target sequences of three short hairpin RNAs for NRG1 are as follows:
These sequences are present in all three major isoforms of NRG1: NRG1 type I, type II, and type III.
Slice Culture, Transfection, and Other Treatments Organotypic hippocampal slices were prepared from postnatal day 6 or 7 rats (Stoppini et al., 1991) , transfected after 4-6 days in culture, and used for electrophysiology or imaging experiments 2-3 days after transfection. Coexpression of two constructs was achieved using biolistics transfection (Arnold et al., 1994) . For experiments using Lenti virus infection, slices were infected after 1 day in culture and used 4-7 days after infection for electrophysiology or 7 days after infection for imaging experiments.
For treatment with gluR2-3Y or -3A peptides, slices were first infected with Lenti virus at day 0. At day 4, the peptides were added to the medium at a concentration of 5 mm. The peptides were replenished every 24 hr. Recordings were made on day 7. The sequences of gluR2-3Y and 3A are the same as previously reported (Ahmadian et al., 2004) . A TAT sequence was fused to peptides to aid delivery into the cell. A dansyl group was also included for visualization of the peptides. Accumulation of the peptides in neurons was readily detectable by two-photon laser scanning microscope at a wavelength of 720 nm (data not shown).
Electrophysiology
Whole-cell recordings were obtained with Axopatch-1D amplifiers (Axon Instruments). To monitor the effects of different constructs on synaptic transmission, slices were either transfected biolisticly or infected with Sindbis or Lenti viruses expressing different constructs. Two days (biolistic), 16-24 hr (Sindbis virus), or 4-7 days (Lenti virus) later, whole-cell recordings were obtained simultaneously from a transfected and an adjacent nontransfected neuron in the CA1 region under visual guidance using epifluorescence and transmitted light illumination. The recording chamber was perfused with artificial cerebrospinal fluid (ACSF) containing 119 mM NaCl, 2.5 mM KCl, 4 mM CaCl 2 , 4 mM MgCl 2 , 26 mM NaHCO 3 , 1 mM NaH 2 PO 4 , 11 mM glucose, 0.1 mM picrotoxin, and 1 mM 2-chloroadenosine (pH 7.4), and gassed with 5% CO 2 /95% O 2 . Recordings were made at 27 C. Patch recording pipettes (3-5 MU) were filled with intracellular solution containing 115 mM cesium methanesulfonate, 20 mM CsCl, 10 mM HEPES, 2.5 mM MgCl 2 , 4 mM Na 2 ATP, 0.4 mM Na 3 GTP, 10 mM sodium phosphocreatine, and 0.6 mM EGTA (pH 7.25). Evoked responses were induced using bipolar electrodes placed on Schaffer collateral pathway or CA3 cell body regions. Responses were recorded at both À60 (for AMPA receptor-mediated responses) and +40 (for NMDA receptormediated responses) mV. NMDA receptor-mediated responses were quantified as the mean between 110 and 160 ms after stimulation. Conventional LTP was induced by pairing postsynaptic depolarization at 0 mV with presynaptic stimulation at 3 Hz for 1.5 min. Approximately one-half of experiments were done and analyzed blind with respect to construct expressed. Results were similar and thus pooled with nonblind results. Statistical significance was determined by Student's t test or Kolmogorov-Smirnov test. Spontaneous responses (mEPSCs) were recorded at 27 C in the presence of 1 mM TTX and 0.1 mM picrotoxin and analyzed using Mini Analysis Program (Synaptosoft). 
